Similar companies
Did Ensysce Biosciences Beat Earnings?
Ensysce Biosciences (ENSC) reported Q3 '24 revenue of $3.4M, with reported EPS of $1.05. That topped the $-2.55 analyst estimate by 141.2% — an earnings beat.
AltIndex tracks earnings alongside 25+ alternative data signals that can move ahead of the report — Ensysce Biosciences’s job postings, web traffic, and employee business outlook. See the full ENSC stock analysis or the earnings calendar for upcoming reports.
Ensysce Biosciences Quarterly Financial Trends
| Metric | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.4M | 1.3M | 1.3M | 1.4M | 490,000 | 1.9M | 960,000 | 1.2M |
| Gross margin | 50.5% | -191.7% | 100.0% | -40.2% | -499.2% | 0.0% | 99.3% | 100.0% |
| Operating margin | 18.9% | -274.3% | -149.1% | -127.6% | -758.7% | -147.8% | -370.7% | -221.3% |
| Net income | 660,000 | -3.6M | -1.9M | -1.7M | -3.7M | -2.8M | -3.6M | -2.6M |
| Net margin | 19.4% | -273.4% | -147.4% | -126.4% | -756.3% | -147.0% | -370.1% | -220.8% |
| EPS | $1.05 | — | — | — | — | — | — | — |
Ensysce Biosciences Earnings Trend Analysis
Over the eight quarters from Q3 '24 to Q2 '26, Ensysce Biosciences’s quarterly revenue moved from $3.4M to $1.2M. Net margin compressed from 19.4% to -220.8%, against a 100% gross margin in the most recent quarter — a read on whether revenue growth is translating into profit. Ensysce Biosciences has beaten Wall Street EPS estimates in 1 of its last 1 reported quarters.
When Is Ensysce Biosciences’s Next Earnings Date?
Ensysce Biosciences reports earnings on a quarterly schedule. Its most recent report covered Q3 '24. For the confirmed upcoming date — and every other company reporting soon — see the ENSC earnings calendar.
Frequently Asked Questions: Ensysce Biosciences Earnings
Ensysce Biosciences's next earnings date has not been confirmed yet. See the earnings calendar for all upcoming reports.
Ensysce Biosciences reported Q3 '24 EPS of $1.05 on revenue of $3.4M. Ensysce Biosciences beat estimates, reporting $1.05 vs. the $-2.55 estimate.
Ensysce Biosciences reported Q3 '24 revenue of $3.4M.
Signals like job postings, web traffic, and employee sentiment reflect business activity in real time and can move before quarterly results are reported. AltIndex combines them with 25+ others in the ENSC AI Score.
